Home › Trial NCT00794235
Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine
- Trial IDNCT00794235
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorUniversity of Zurich
- Enrollment12
- Start date2008-12
- ConditionsMelanoma Stage III or IV · No Prior Chemotherapy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.